You have no items in your shopping cart.
Availability: In Stock
Brand Name : Ultravist 300mg I/ml Injection
Composition : Iopromide (300mg I/ml)
Manufactured By : Zydus Cadila
Form : vial
Packing : 50 ml in 1 vial
Ultravist 300mg I/ml Injection Description:
Iopromide belongs to a class of drugs known as Iodinated radiographic contrast agent. It enhances imaging due to its high Iodine content attenuating the beam of X-rays during examination.
Ultravist 300mg I/ml Injection is used in diagnosis of disease of spinal cord.
Headache, Altered taste, Vomiting, Chest pain, Injection site pain, Back pain, Nausea, Infusion site reaction, Abnormal vision, Decreased blood pressure, Frequent urge to urinate.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Is Iopromide radioactive?
No. Iopromide is not radioactive
Is Iopromide water soluble?
Yes. Iopromide is a water soluble X-ray contrast agent for intravascular administration.
Buy Ultravist 300mg I/ml Injection Online From India At Best Price
If you are looking to buy Iopromide (300mg I/ml) (50 ml in 1 vial) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Ultravist 300mg I/ml Injection in -
South East Asia - China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) - Iran, Saudi Arabia, Jordan.
North America - Venezuela, USA (United States of America), Suriname.
South America - Argentina, Chile, Colombia, Peru, Venezuela.
Europe - Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS - Moldova, Uzbekistan, Kyrgyzstan.
African Countries - Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries - Malaysia, Egypt, Australia, Italy and New Zealand.